Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

25.44 -0.56 (-2.15%)
Streaming Delayed Price Updated: 9:54 AM EDT, Sep 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Twist Bioscience to Present at Baird 2025 Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Collaborates with Synthetic Design Lab
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution
From Twist Bioscience Corporation
Via Business Wire
Earnings Scheduled For August 4, 2025
 
Via Benzinga
Twist Bioscience Appoints Trynka Shineman Blake to Board of Directors
From Twist Bioscience Corporation
Via Business Wire
Cathie Wood's Ark Dumps Block Stock Worth $4.8 Million As Bitcoin-Heavy Company Preps Q2 Results
Cathie Wood-led Ark Invest executed a significant trade in Block Inc. (NYSE:XYZ) on Tuesday. 
Via Benzinga
Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings
Twist Bioscience beat Q3 revenue estimates, improved gross margins, and narrowed its full-year outlook while forecasting EBITDA breakeven fiscal 2026. 
Via Benzinga
Preview: Twist Bioscience's Earnings
 
Via Benzinga
Earnings Scheduled For May 5, 2025
 
Via Benzinga
What's Next: Twist Bioscience's Earnings Preview
 
Via Benzinga
Twist Bioscience (TWST) Q3 Profit Surges
Via The Motley Fool
Twist Bioscience Corp (NASDAQ:TWST) Reports Mixed Q3 2025 Results with Revenue Miss and EPS Beat
Twist Bioscience reported mixed Q3 2025 results, missing revenue estimates at $96.06M but beating EPS at -$0.47. Shares fell 5% pre-market as investors focused on the sales shortfall. 
Via Chartmill
Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Report Fiscal 2025 Third Quarter Financial Results on Monday, August 4, 2025
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Expands Express Delivery Turnaround Time to All Gene Fragments Regardless of Format
From Twist Bioscience Corporation
Via Business Wire
Cathie Wood's Ark Invest Continues To Offload Coinbase, Bets Big On SoFi Technologies
Cathie Wood-led Ark Invest made notable trades on Friday, including selling shares in Coinbase and Roblox. 
Via Benzinga
Cathie Wood Reiterates 'Profound' AI Application In Healthcare As Researchers Discover 'Cancer Survival Outcomes' By Facial Photograph Analysis: Here Are The Stocks That Could Benefit
Cathie Wood underscored the application of AI in the healthcare sector by sharing new research by Mass General Brigham. 
Via Benzinga
Topics Artificial Intelligence
Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots
Cathie Wood highlights the rising applications of AI and how it is poised to impact the health care space. 
Via Benzinga
Topics Artificial Intelligence
Twist Bioscience and Ginkgo Bioworks Revise Collaboration
From Twist Bioscience Corporation
Via Business Wire
Where Twist Bioscience Stands With Analysts
 
Via Benzinga
Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Spins Out DNA Data Storage as Independent Company
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Report Fiscal 2025 Second Quarter Financial Results on Monday, May 5, 2025
From Twist Bioscience Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.